GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (HKSE:01873) » Definitions » PB Ratio

Viva Biotech Holdings (HKSE:01873) PB Ratio : 0.33 (As of Jun. 06, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-06), Viva Biotech Holdings's share price is HK$0.62. Viva Biotech Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was HK$1.88. Hence, Viva Biotech Holdings's PB Ratio of today is 0.33.

The historical rank and industry rank for Viva Biotech Holdings's PB Ratio or its related term are showing as below:

HKSE:01873' s PB Ratio Range Over the Past 10 Years
Min: 0.22   Med: 2.2   Max: 26.84
Current: 0.33

During the past 8 years, Viva Biotech Holdings's highest PB Ratio was 26.84. The lowest was 0.22. And the median was 2.20.

HKSE:01873's PB Ratio is ranked better than
96.63% of 1307 companies
in the Biotechnology industry
Industry Median: 2.54 vs HKSE:01873: 0.33

During the past 12 months, Viva Biotech Holdings's average Book Value Per Share Growth Rate was -10.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 45.20% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Viva Biotech Holdings was 181.10% per year. The lowest was -6.90% per year. And the median was 136.10% per year.

Back to Basics: PB Ratio


Viva Biotech Holdings PB Ratio Historical Data

The historical data trend for Viva Biotech Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings PB Ratio Chart

Viva Biotech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial 3.60 3.93 1.88 0.83 0.56

Viva Biotech Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.88 1.13 0.83 0.72 0.56

Competitive Comparison of Viva Biotech Holdings's PB Ratio

For the Biotechnology subindustry, Viva Biotech Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viva Biotech Holdings's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Viva Biotech Holdings's PB Ratio falls into.



Viva Biotech Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Viva Biotech Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.62/1.883
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Viva Biotech Holdings  (HKSE:01873) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Viva Biotech Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Viva Biotech Holdings (HKSE:01873) Business Description

Traded in Other Exchanges
Address
735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318
Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation ("CDMO") and commercialisation services segment includes contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations.
Executives
Mao Chen Cheney 2101 Beneficial owner
Wu John Jiong 2201 Interest of corporation controlled by you
Fenghe Harvest Ltd 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Mao Jun 2501 Other
Temasek Holdings (private) Limited 2201 Interest of corporation controlled by you
Zhou Min 2202 Interest of your spouse
Intertrust (singapore) Ltd. 2301 Trustee
Z&m International Holdings Limited 2201 Interest of corporation controlled by you
Zhang And Sons Limited 2101 Beneficial owner

Viva Biotech Holdings (HKSE:01873) Headlines

No Headlines